BIIB vs XTIA · P/E 21, rev $9.89B vs rev $3.2M
Biogen Inc (BIIB) versus XTI Aerospace, Inc. (XTIA) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
XTI Aerospace, Inc. (XTIA) is a aerospace & defense company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported XTIA revenue for 2024-12-31 was $3.2M. Net income was -$35.6M. Revenue was down 29.8% from 2023-12-31 to 2024-12-31. XTIA currently screens at market cap $69.3M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. XTIA currently screens at market cap $69.3M.
Not investment advice. Open the BIIB and XTIA stock pages for the full models.
Not investment advice.